Manufacturer:
Novartis
Route of Administration:
Intravenous
Site of Care:
Outpatient
Website:
phone:
1-800-282-7630
Approved Indication:
to reduce the frequency of vasoocclusive crises in adults and pediatric patients aged 16 years and older with sickle cell disease
Conditions:
- Sickle Cell Disease1